Share Price and Basic Stock Data
Last Updated: November 3, 2025, 11:29 pm
| PEG Ratio | 6.70 | 
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
COSYN Ltd, operating in the IT Consulting & Software sector, reported a current market capitalization of ₹18.5 Cr and a share price of ₹24.7. The company’s revenue trajectory has shown fluctuations, with total sales standing at ₹14.84 Cr for the fiscal year ending March 2023, a slight increase from ₹13.41 Cr in the previous year. However, the trailing twelve months revenue dipped to ₹12.09 Cr, indicating a potential decline in demand or operational challenges. Quarterly sales figures reflected this volatility, peaking at ₹5.16 Cr in September 2022 before falling to ₹3.11 Cr in June 2023. The latest quarter reported sales of ₹4.20 Cr, suggesting a recovery trend. Overall, revenue growth has been inconsistent, which could raise concerns about market positioning and competitive strength in the IT consulting landscape.
Profitability and Efficiency Metrics
The profitability metrics of COSYN Ltd indicate a challenging environment, with a reported net profit of ₹0.16 Cr for the fiscal year ending March 2025, which is marginally higher than the ₹0.07 Cr recorded in March 2022. The operating profit margin (OPM) stood at 46.48% in the most recent quarter, reflecting a significant recovery from negative margins earlier in the year. However, the annual OPM has fluctuated, with a low of -6.04% in March 2022. The company’s return on equity (ROE) is reported at 5.63%, while return on capital employed (ROCE) is at 3.13%, both of which are below typical sector standards. Additionally, the cash conversion cycle (CCC) is alarmingly high at 2,528.39 days, indicating inefficiencies in managing receivables and inventory, which could hinder cash flow and operational agility.
Balance Sheet Strength and Financial Ratios
COSYN Ltd’s balance sheet reflects a cautious financial strategy, with total borrowings reported at ₹2.05 Cr, maintaining a low debt-to-equity ratio of 0.00, suggesting minimal reliance on external financing. The company’s reserves have increased to ₹22.26 Cr, providing a buffer against operational risks. However, the interest coverage ratio (ICR) is reported at 3.57x, which, while adequate, indicates a potential vulnerability if profitability does not improve. The price-to-book value (P/BV) ratio stands at 0.57x, signaling that the stock may be undervalued compared to its book value. Despite these strengths, the company’s financial performance must improve for sustained investor confidence, especially given the historical volatility in sales and profitability.
Shareholding Pattern and Investor Confidence
The shareholding structure of COSYN Ltd shows a prominent promoter holding of 54.46%, indicating significant insider control. The public holds 45.55% of the shares, with no foreign institutional investors (FIIs) and domestic institutional investors (DIIs) holding a negligible stake of 0.00%. The number of shareholders stood at 4,880, which reflects a slight decline from earlier periods but still indicates a reasonable level of public interest. The absence of institutional backing may raise concerns about perceived risk among larger investors. While promoter confidence is evident, the lack of institutional investment could imply broader market apprehension regarding the company’s future growth and operational efficiency.
Outlook, Risks, and Final Insight
Looking ahead, COSYN Ltd faces both opportunities and risks. The potential for revenue recovery exists if the company can stabilize its operational efficiencies and improve cash flow management. However, the high cash conversion cycle poses a significant risk, as it suggests prolonged periods of capital being tied up in receivables and inventory. Additionally, the fluctuating profitability metrics indicate an unstable operational environment that could deter new investments. If COSYN can leverage its strong promoter ownership to enhance operational strategies and investor relations, it may attract institutional interest, thereby improving its market position. Conversely, continued volatility in financial performance without strategic changes may lead to further declines in investor confidence.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of COSYN Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ | 
|---|---|---|---|---|---|---|---|---|---|
| Visesh Infotecnics Ltd | 125 Cr. | 0.33 | 0.38/0.33 | 1.12 | 0.00 % | 2.21 % | 2.23 % | 1.00 | |
| Mudunuru Ltd | 33.6 Cr. | 10.6 | 10.6/4.43 | 0.25 | 0.00 % | 27.0 % | 90.7 % | 2.00 | |
| Naapbooks Ltd | 157 Cr. | 146 | 194/99.8 | 35.1 | 33.2 | 0.00 % | 23.6 % | 17.1 % | 10.0 | 
| IB Infotech Enterprises Ltd | 32.9 Cr. | 257 | 310/140 | 23.5 | 26.7 | 0.39 % | 38.5 % | 35.4 % | 10.0 | 
| Hit Kit Global Solutions Ltd | 6.55 Cr. | 1.34 | 1.73/0.91 | 59.6 | 2.52 | 0.00 % | 2.14 % | 2.15 % | 2.00 | 
| Industry Average | 19,272.22 Cr | 570.43 | 144.55 | 119.27 | 0.53% | 14.92% | 20.95% | 6.84 | 
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | 
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2.98 | 5.16 | 3.29 | 3.65 | 3.11 | 4.20 | 3.39 | 4.80 | 3.43 | 3.29 | 3.31 | 4.78 | 0.71 | 
| Expenses | 2.64 | 4.73 | 3.01 | 3.40 | 4.09 | 3.66 | 3.19 | 3.65 | 3.21 | 3.08 | 3.05 | 6.30 | 0.38 | 
| Operating Profit | 0.34 | 0.43 | 0.28 | 0.25 | -0.98 | 0.54 | 0.20 | 1.15 | 0.22 | 0.21 | 0.26 | -1.52 | 0.33 | 
| OPM % | 11.41% | 8.33% | 8.51% | 6.85% | -31.51% | 12.86% | 5.90% | 23.96% | 6.41% | 6.38% | 7.85% | -31.80% | 46.48% | 
| Other Income | 0.05 | 0.05 | 0.05 | 0.08 | 0.06 | 0.07 | 0.07 | 0.03 | 0.02 | 0.01 | 0.01 | 2.13 | 0.04 | 
| Interest | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.05 | 0.06 | 0.04 | 0.06 | 0.07 | 0.06 | 0.17 | 0.12 | 
| Depreciation | 0.23 | 0.24 | 0.24 | 0.25 | 0.19 | 0.19 | 0.20 | 0.20 | 0.13 | 0.13 | 0.14 | 0.16 | 0.20 | 
| Profit before tax | 0.14 | 0.22 | 0.07 | 0.06 | -1.13 | 0.37 | 0.01 | 0.94 | 0.05 | 0.02 | 0.07 | 0.28 | 0.05 | 
| Tax % | 35.71% | 27.27% | 42.86% | 83.33% | 0.88% | 2.70% | 100.00% | 13.83% | 20.00% | 50.00% | 28.57% | 75.00% | 20.00% | 
| Net Profit | 0.09 | 0.16 | 0.04 | 0.01 | -1.14 | 0.36 | 0.00 | 0.82 | 0.04 | 0.01 | 0.04 | 0.07 | 0.04 | 
| EPS in Rs | 0.12 | 0.21 | 0.05 | 0.01 | -1.52 | 0.48 | 0.00 | 1.09 | 0.05 | 0.01 | 0.05 | 0.09 | 0.05 | 
Last Updated: August 19, 2025, 8:40 pm
Below is a detailed analysis of the quarterly data for COSYN Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 0.71 Cr.. The value appears to be declining and may need further review. It has decreased from 4.78 Cr. (Mar 2025) to 0.71 Cr., marking a decrease of 4.07 Cr..
 - For Expenses, as of Jun 2025, the value is 0.38 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 6.30 Cr. (Mar 2025) to 0.38 Cr., marking a decrease of 5.92 Cr..
 - For Operating Profit, as of Jun 2025, the value is 0.33 Cr.. The value appears strong and on an upward trend. It has increased from -1.52 Cr. (Mar 2025) to 0.33 Cr., marking an increase of 1.85 Cr..
 - For OPM %, as of Jun 2025, the value is 46.48%. The value appears strong and on an upward trend. It has increased from -31.80% (Mar 2025) to 46.48%, marking an increase of 78.28%.
 - For Other Income, as of Jun 2025, the value is 0.04 Cr.. The value appears to be declining and may need further review. It has decreased from 2.13 Cr. (Mar 2025) to 0.04 Cr., marking a decrease of 2.09 Cr..
 - For Interest, as of Jun 2025, the value is 0.12 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.17 Cr. (Mar 2025) to 0.12 Cr., marking a decrease of 0.05 Cr..
 - For Depreciation, as of Jun 2025, the value is 0.20 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.16 Cr. (Mar 2025) to 0.20 Cr., marking an increase of 0.04 Cr..
 - For Profit before tax, as of Jun 2025, the value is 0.05 Cr.. The value appears to be declining and may need further review. It has decreased from 0.28 Cr. (Mar 2025) to 0.05 Cr., marking a decrease of 0.23 Cr..
 - For Tax %, as of Jun 2025, the value is 20.00%. The value appears to be improving (decreasing) as expected. It has decreased from 75.00% (Mar 2025) to 20.00%, marking a decrease of 55.00%.
 - For Net Profit, as of Jun 2025, the value is 0.04 Cr.. The value appears to be declining and may need further review. It has decreased from 0.07 Cr. (Mar 2025) to 0.04 Cr., marking a decrease of 0.03 Cr..
 - For EPS in Rs, as of Jun 2025, the value is 0.05. The value appears to be declining and may need further review. It has decreased from 0.09 (Mar 2025) to 0.05, marking a decrease of 0.04.
 
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 3:35 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | 
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 12.50 | 22.08 | 27.71 | 31.47 | 42.70 | 39.57 | 29.90 | 19.89 | 13.41 | 14.84 | 13.73 | 14.38 | 12.09 | 
| Expenses | 10.07 | 19.29 | 23.08 | 23.87 | 31.63 | 33.06 | 24.63 | 17.49 | 14.22 | 13.45 | 12.55 | 14.92 | 12.81 | 
| Operating Profit | 2.43 | 2.79 | 4.63 | 7.60 | 11.07 | 6.51 | 5.27 | 2.40 | -0.81 | 1.39 | 1.18 | -0.54 | -0.72 | 
| OPM % | 19.44% | 12.64% | 16.71% | 24.15% | 25.93% | 16.45% | 17.63% | 12.07% | -6.04% | 9.37% | 8.59% | -3.76% | -5.96% | 
| Other Income | 0.04 | 0.07 | 0.21 | 0.24 | 0.32 | 0.43 | 0.28 | 0.29 | 2.76 | 0.23 | 0.23 | 2.18 | 2.19 | 
| Interest | 0.42 | 0.42 | 0.45 | 0.28 | 1.71 | 1.81 | 0.54 | 0.23 | 0.08 | 0.17 | 0.44 | 0.66 | 0.42 | 
| Depreciation | 0.80 | 0.97 | 0.75 | 0.85 | 0.94 | 1.76 | 2.64 | 2.38 | 1.71 | 0.96 | 0.77 | 0.56 | 0.63 | 
| Profit before tax | 1.25 | 1.47 | 3.64 | 6.71 | 8.74 | 3.37 | 2.37 | 0.08 | 0.16 | 0.49 | 0.20 | 0.42 | 0.42 | 
| Tax % | 34.40% | -46.26% | -2.20% | 2.09% | 18.76% | 30.56% | 20.68% | 25.00% | 62.50% | 38.78% | 75.00% | 59.52% | |
| Net Profit | 0.82 | 2.14 | 3.71 | 6.57 | 7.09 | 2.34 | 1.88 | 0.06 | 0.07 | 0.30 | 0.04 | 0.16 | 0.16 | 
| EPS in Rs | 1.10 | 2.85 | 4.95 | 8.76 | 9.45 | 3.12 | 2.51 | 0.08 | 0.09 | 0.40 | 0.05 | 0.21 | 0.20 | 
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 11.42% | 10.58% | 16.03% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 | 
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 160.98% | 73.36% | 77.09% | 7.91% | -67.00% | -19.66% | -96.81% | 16.67% | 328.57% | -86.67% | 300.00% | 
| Change in YoY Net Profit Growth (%) | 0.00% | -87.61% | 3.72% | -69.17% | -74.91% | 47.34% | -77.15% | 113.48% | 311.90% | -415.24% | 386.67% | 
COSYN Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -4% | 
| 5 Years: | -13% | 
| 3 Years: | 3% | 
| TTM: | -24% | 
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -23% | 
| 5 Years: | -39% | 
| 3 Years: | 32% | 
| TTM: | -87% | 
| Stock Price CAGR | |
|---|---|
| 10 Years: | 6% | 
| 5 Years: | 1% | 
| 3 Years: | 9% | 
| 1 Year: | -53% | 
| Return on Equity | |
|---|---|
| 10 Years: | 8% | 
| 5 Years: | 0% | 
| 3 Years: | 1% | 
| Last Year: | 1% | 
Last Updated: September 5, 2025, 3:06 pm
Balance Sheet
Last Updated: October 10, 2025, 3:49 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | 
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 7.42 | 7.50 | 7.50 | 7.50 | 7.50 | 7.50 | 7.50 | 7.50 | 7.50 | 7.50 | 7.50 | 7.50 | 
| Reserves | 3.85 | 4.43 | 8.15 | 14.20 | 20.39 | 22.22 | 21.68 | 21.69 | 21.76 | 22.06 | 22.10 | 22.26 | 
| Borrowings | 2.28 | 2.55 | 2.39 | 0.85 | 4.42 | 3.56 | 1.39 | 0.33 | 0.66 | 0.49 | 1.79 | 2.05 | 
| Other Liabilities | 9.30 | 9.39 | 9.88 | 11.67 | 7.03 | 10.26 | 12.81 | 7.30 | 6.74 | 6.75 | 6.19 | 7.91 | 
| Total Liabilities | 22.85 | 23.87 | 27.92 | 34.22 | 39.34 | 43.54 | 43.38 | 36.82 | 36.66 | 36.80 | 37.58 | 39.72 | 
| Fixed Assets | 4.89 | 2.78 | 3.40 | 3.43 | 3.59 | 7.66 | 6.24 | 4.86 | 6.65 | 6.25 | 5.68 | 3.79 | 
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 1.31 | 0.00 | 0.61 | 1.17 | 1.18 | 1.58 | 2.38 | 2.23 | 
| Investments | 0.00 | 0.00 | 0.01 | 1.84 | 2.20 | 2.28 | 2.31 | 2.34 | 2.38 | 2.42 | 2.42 | 2.42 | 
| Other Assets | 17.96 | 21.09 | 24.51 | 28.95 | 32.24 | 33.60 | 34.22 | 28.45 | 26.45 | 26.55 | 27.10 | 31.28 | 
| Total Assets | 22.85 | 23.87 | 27.92 | 34.22 | 39.34 | 43.54 | 43.38 | 36.82 | 36.66 | 36.80 | 37.58 | 39.72 | 
Below is a detailed analysis of the balance sheet data for COSYN Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 7.50 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 7.50 Cr..
 - For Reserves, as of Mar 2025, the value is 22.26 Cr.. The value appears strong and on an upward trend. It has increased from 22.10 Cr. (Mar 2024) to 22.26 Cr., marking an increase of 0.16 Cr..
 - For Borrowings, as of Mar 2025, the value is 2.05 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 1.79 Cr. (Mar 2024) to 2.05 Cr., marking an increase of 0.26 Cr..
 - For Other Liabilities, as of Mar 2025, the value is 7.91 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 6.19 Cr. (Mar 2024) to 7.91 Cr., marking an increase of 1.72 Cr..
 - For Total Liabilities, as of Mar 2025, the value is 39.72 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 37.58 Cr. (Mar 2024) to 39.72 Cr., marking an increase of 2.14 Cr..
 - For Fixed Assets, as of Mar 2025, the value is 3.79 Cr.. The value appears to be declining and may need further review. It has decreased from 5.68 Cr. (Mar 2024) to 3.79 Cr., marking a decrease of 1.89 Cr..
 - For CWIP, as of Mar 2025, the value is 2.23 Cr.. The value appears to be declining and may need further review. It has decreased from 2.38 Cr. (Mar 2024) to 2.23 Cr., marking a decrease of 0.15 Cr..
 - For Investments, as of Mar 2025, the value is 2.42 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 2.42 Cr..
 - For Other Assets, as of Mar 2025, the value is 31.28 Cr.. The value appears strong and on an upward trend. It has increased from 27.10 Cr. (Mar 2024) to 31.28 Cr., marking an increase of 4.18 Cr..
 - For Total Assets, as of Mar 2025, the value is 39.72 Cr.. The value appears strong and on an upward trend. It has increased from 37.58 Cr. (Mar 2024) to 39.72 Cr., marking an increase of 2.14 Cr..
 
Notably, the Reserves (22.26 Cr.) exceed the Borrowings (2.05 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | 
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 0.15 | 0.24 | 2.24 | 6.75 | 6.65 | 2.95 | 3.88 | 2.07 | -1.47 | 0.90 | -0.61 | -2.59 | 
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | 
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 116.80 | 118.36 | 170.58 | 198.10 | 84.97 | 188.27 | 209.60 | 244.98 | 340.23 | 267.11 | 332.04 | 347.99 | 
| Inventory Days | 804.21 | 316.12 | 34.44 | 2,377.30 | ||||||||
| Days Payable | 714.85 | 606.16 | 118.98 | 196.91 | ||||||||
| Cash Conversion Cycle | 116.80 | 118.36 | 259.94 | -91.94 | 84.97 | 103.72 | 209.60 | 244.98 | 340.23 | 267.11 | 332.04 | 2,528.39 | 
| Working Capital Days | 95.78 | 79.02 | 109.20 | 110.76 | 80.61 | 95.01 | 117.56 | 200.76 | 290.97 | 248.91 | 323.53 | 287.37 | 
| ROCE % | 13.44% | 13.49% | 25.15% | 34.44% | 38.10% | 15.80% | 9.27% | 1.03% | 0.81% | 2.20% | 2.08% | 2.62% | 
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | 
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 
| Basic EPS (Rs.) | 0.21 | 0.05 | 0.33 | -0.20 | -0.54 | 
| Diluted EPS (Rs.) | 0.21 | 0.05 | 0.33 | -0.20 | -0.54 | 
| Cash EPS (Rs.) | 0.96 | 1.08 | 1.63 | 2.33 | 3.20 | 
| Book Value[Excl.RevalReserv]/Share (Rs.) | 36.56 | 36.35 | 36.38 | 36.05 | 36.26 | 
| Book Value[Incl.RevalReserv]/Share (Rs.) | 36.56 | 36.35 | 36.38 | 36.05 | 36.26 | 
| Revenue From Operations / Share (Rs.) | 19.74 | 20.67 | 20.10 | 17.93 | 26.53 | 
| PBDIT / Share (Rs.) | 1.81 | 1.52 | 2.00 | 2.50 | 3.45 | 
| PBIT / Share (Rs.) | 1.06 | 0.48 | 0.69 | -0.04 | -0.30 | 
| PBT / Share (Rs.) | 0.54 | 0.25 | 0.58 | -0.08 | -0.53 | 
| Net Profit / Share (Rs.) | 0.21 | 0.04 | 0.32 | -0.21 | -0.56 | 
| NP After MI And SOA / Share (Rs.) | 0.21 | 0.04 | 0.32 | -0.20 | -0.53 | 
| PBDIT Margin (%) | 9.17 | 7.34 | 9.93 | 13.96 | 12.99 | 
| PBIT Margin (%) | 5.35 | 2.32 | 3.45 | -0.22 | -1.16 | 
| PBT Margin (%) | 2.78 | 1.21 | 2.88 | -0.48 | -2.01 | 
| Net Profit Margin (%) | 1.07 | 0.22 | 1.63 | -1.17 | -2.11 | 
| NP After MI And SOA Margin (%) | 1.07 | 0.22 | 1.63 | -1.12 | -2.02 | 
| Return on Networth / Equity (%) | 0.58 | 0.12 | 0.90 | -0.56 | -1.48 | 
| Return on Capital Employeed (%) | 2.87 | 1.31 | 1.88 | -0.10 | -0.84 | 
| Return On Assets (%) | 0.42 | 0.09 | 0.71 | -0.43 | -1.15 | 
| Long Term Debt / Equity (X) | 0.00 | 0.00 | 0.01 | 0.01 | 0.00 | 
| Total Debt / Equity (X) | 0.00 | 0.00 | 0.01 | 0.01 | 0.00 | 
| Asset Turnover Ratio (%) | 0.40 | 0.44 | 0.42 | 0.37 | 0.50 | 
| Current Ratio (X) | 2.75 | 2.87 | 3.22 | 3.26 | 3.28 | 
| Quick Ratio (X) | 2.25 | 2.23 | 2.69 | 2.81 | 2.85 | 
| Inventory Turnover Ratio (X) | 0.13 | 0.15 | 0.19 | 0.19 | 0.19 | 
| Interest Coverage Ratio (X) | 3.57 | 6.60 | 17.71 | 53.52 | 15.24 | 
| Interest Coverage Ratio (Post Tax) (X) | 1.42 | 1.20 | 3.91 | -3.49 | -1.48 | 
| Enterprise Value (Cr.) | 10.24 | 23.94 | 8.25 | 11.51 | 8.95 | 
| EV / Net Operating Revenue (X) | 0.69 | 1.54 | 0.54 | 0.85 | 0.44 | 
| EV / EBITDA (X) | 7.54 | 21.03 | 5.50 | 6.13 | 3.46 | 
| MarketCap / Net Operating Revenue (X) | 1.06 | 1.70 | 0.88 | 1.17 | 0.75 | 
| Price / BV (X) | 0.57 | 0.96 | 0.48 | 0.58 | 0.55 | 
| Price / Net Operating Revenue (X) | 1.06 | 1.70 | 0.88 | 1.17 | 0.75 | 
| EarningsYield | 0.01 | 0.00 | 0.01 | -0.01 | -0.02 | 
After reviewing the key financial ratios for COSYN Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
 - For Basic EPS (Rs.), as of Mar 25, the value is 0.21. This value is below the healthy minimum of 5. It has increased from 0.05 (Mar 24) to 0.21, marking an increase of 0.16.
 - For Diluted EPS (Rs.), as of Mar 25, the value is 0.21. This value is below the healthy minimum of 5. It has increased from 0.05 (Mar 24) to 0.21, marking an increase of 0.16.
 - For Cash EPS (Rs.), as of Mar 25, the value is 0.96. This value is below the healthy minimum of 3. It has decreased from 1.08 (Mar 24) to 0.96, marking a decrease of 0.12.
 - For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 36.56. It has increased from 36.35 (Mar 24) to 36.56, marking an increase of 0.21.
 - For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 36.56. It has increased from 36.35 (Mar 24) to 36.56, marking an increase of 0.21.
 - For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 19.74. It has decreased from 20.67 (Mar 24) to 19.74, marking a decrease of 0.93.
 - For PBDIT / Share (Rs.), as of Mar 25, the value is 1.81. This value is below the healthy minimum of 2. It has increased from 1.52 (Mar 24) to 1.81, marking an increase of 0.29.
 - For PBIT / Share (Rs.), as of Mar 25, the value is 1.06. This value is within the healthy range. It has increased from 0.48 (Mar 24) to 1.06, marking an increase of 0.58.
 - For PBT / Share (Rs.), as of Mar 25, the value is 0.54. This value is within the healthy range. It has increased from 0.25 (Mar 24) to 0.54, marking an increase of 0.29.
 - For Net Profit / Share (Rs.), as of Mar 25, the value is 0.21. This value is below the healthy minimum of 2. It has increased from 0.04 (Mar 24) to 0.21, marking an increase of 0.17.
 - For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 0.21. This value is below the healthy minimum of 2. It has increased from 0.04 (Mar 24) to 0.21, marking an increase of 0.17.
 - For PBDIT Margin (%), as of Mar 25, the value is 9.17. This value is below the healthy minimum of 10. It has increased from 7.34 (Mar 24) to 9.17, marking an increase of 1.83.
 - For PBIT Margin (%), as of Mar 25, the value is 5.35. This value is below the healthy minimum of 10. It has increased from 2.32 (Mar 24) to 5.35, marking an increase of 3.03.
 - For PBT Margin (%), as of Mar 25, the value is 2.78. This value is below the healthy minimum of 10. It has increased from 1.21 (Mar 24) to 2.78, marking an increase of 1.57.
 - For Net Profit Margin (%), as of Mar 25, the value is 1.07. This value is below the healthy minimum of 5. It has increased from 0.22 (Mar 24) to 1.07, marking an increase of 0.85.
 - For NP After MI And SOA Margin (%), as of Mar 25, the value is 1.07. This value is below the healthy minimum of 8. It has increased from 0.22 (Mar 24) to 1.07, marking an increase of 0.85.
 - For Return on Networth / Equity (%), as of Mar 25, the value is 0.58. This value is below the healthy minimum of 15. It has increased from 0.12 (Mar 24) to 0.58, marking an increase of 0.46.
 - For Return on Capital Employeed (%), as of Mar 25, the value is 2.87. This value is below the healthy minimum of 10. It has increased from 1.31 (Mar 24) to 2.87, marking an increase of 1.56.
 - For Return On Assets (%), as of Mar 25, the value is 0.42. This value is below the healthy minimum of 5. It has increased from 0.09 (Mar 24) to 0.42, marking an increase of 0.33.
 - For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.00.
 - For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.00.
 - For Asset Turnover Ratio (%), as of Mar 25, the value is 0.40. It has decreased from 0.44 (Mar 24) to 0.40, marking a decrease of 0.04.
 - For Current Ratio (X), as of Mar 25, the value is 2.75. This value is within the healthy range. It has decreased from 2.87 (Mar 24) to 2.75, marking a decrease of 0.12.
 - For Quick Ratio (X), as of Mar 25, the value is 2.25. This value exceeds the healthy maximum of 2. It has increased from 2.23 (Mar 24) to 2.25, marking an increase of 0.02.
 - For Inventory Turnover Ratio (X), as of Mar 25, the value is 0.13. This value is below the healthy minimum of 4. It has decreased from 0.15 (Mar 24) to 0.13, marking a decrease of 0.02.
 - For Interest Coverage Ratio (X), as of Mar 25, the value is 3.57. This value is within the healthy range. It has decreased from 6.60 (Mar 24) to 3.57, marking a decrease of 3.03.
 - For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.42. This value is below the healthy minimum of 3. It has increased from 1.20 (Mar 24) to 1.42, marking an increase of 0.22.
 - For Enterprise Value (Cr.), as of Mar 25, the value is 10.24. It has decreased from 23.94 (Mar 24) to 10.24, marking a decrease of 13.70.
 - For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.69. This value is below the healthy minimum of 1. It has decreased from 1.54 (Mar 24) to 0.69, marking a decrease of 0.85.
 - For EV / EBITDA (X), as of Mar 25, the value is 7.54. This value is within the healthy range. It has decreased from 21.03 (Mar 24) to 7.54, marking a decrease of 13.49.
 - For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.06. This value is within the healthy range. It has decreased from 1.70 (Mar 24) to 1.06, marking a decrease of 0.64.
 - For Price / BV (X), as of Mar 25, the value is 0.57. This value is below the healthy minimum of 1. It has decreased from 0.96 (Mar 24) to 0.57, marking a decrease of 0.39.
 - For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.06. This value is within the healthy range. It has decreased from 1.70 (Mar 24) to 1.06, marking a decrease of 0.64.
 - For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. It has increased from 0.00 (Mar 24) to 0.01, marking an increase of 0.01.
 
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness | 
|---|---|
  | 
  | 
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in COSYN Ltd:
-  Net Profit Margin: 1.07%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
 
 -  ROCE: 2.87% (Industry Average ROCE: 14.92%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
 
 -  ROE%: 0.58% (Industry Average ROE: 20.95%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
 
 -  Interest Coverage Ratio (Post Tax): 1.42
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
 
 -  Quick Ratio: 2.25
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
 
 -  Stock P/E: 116 (Industry average Stock P/E: 144.55)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
 
 -  Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
 
 
Stock Rating: -  Net Profit Margin: 1.07%
 
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT | 
|---|---|---|
| IT Consulting & Software | 3rd Floor, TP House, D.No 1 98/9/J/15, Plot No 15(P), Hyderabad Telangana 500081 | comsec@cosyn.in http://www.cosyn.in  | 
| Management | |
|---|---|
| Name | Position Held | 
| Mr. Ravi Vishnu | Managing Director | 
| Mr. Bhopal Reddy | Executive Director | 
| Mrs. Ravi Kasturi | Non Executive Woman Director | 
| Mr. Rama Rao Karumanchi | Independent Director | 
| Mr. Panduranga Murthy Vistakula | Independent Director | 
| Mr. Chennaiah Athota | Independent Director | 
FAQ
What is the intrinsic value of COSYN Ltd?
COSYN Ltd's intrinsic value (as of 03 November 2025) is 211.57 which is 756.56% higher the current market price of 24.70, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's 18.5 Cr. market cap, FY2025-2026 high/low of 53.0/20.4, reserves of ₹22.26 Cr, and liabilities of 39.72 Cr.
What is the Market Cap of COSYN Ltd?
The Market Cap of COSYN Ltd is 18.5 Cr..
What is the current Stock Price of COSYN Ltd as on 03 November 2025?
The current stock price of COSYN Ltd as on 03 November 2025 is 24.7.
What is the High / Low of COSYN Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of COSYN Ltd stocks is 53.0/20.4.
What is the Stock P/E of COSYN Ltd?
The Stock P/E of COSYN Ltd is 116.
What is the Book Value of COSYN Ltd?
The Book Value of COSYN Ltd is 39.7.
What is the Dividend Yield of COSYN Ltd?
The Dividend Yield of COSYN Ltd is 0.00 %.
What is the ROCE of COSYN Ltd?
The ROCE of COSYN Ltd is 3.13 %.
What is the ROE of COSYN Ltd?
The ROE of COSYN Ltd is 5.63 %.
What is the Face Value of COSYN Ltd?
The Face Value of COSYN Ltd is 10.0.

